p.112 抽出テキスト

PMID: 22350775 161. 本村昇, 高本眞一.心臓血管外科データベースの現状.山口徹 編. Annual Review 循環器 2009.中外医学社 2009: 348-354. 162. Motomura N, Miyata H, Tsukihara H, et al. Japan Cardiovascular Surgery Database Organization. First report on 30-day and operative mortality in risk model of isolated coronary artery bypass grafting in Japan. Ann Thorac Surg 2008; 86: 1866-1872. PMID: 19021998 163. Miyata H, Motomura N, Tsukihara H, et al. Japan Cardiovascular Surgery Database. Risk models including high-risk cardiovascular procedures: clinical predictors of mortality and morbidity. Eur J Cardiothorac Surg 2011; 39: 667-674. PMID: 21050770 164. Mandel M, Simchen ES, Zitser-Gurevich Y. Does the EuroSCORE perform well on the STS population? Eur J Cardiothorac Surg 2003; 24: 336-337. PMID: 12895645 165. Borde D, Gandhe U, Hargave N, et al. The application of European system for cardiac operative risk evaluation II (EuroSCORE II) and Society of Thoracic Surgeons (STS) risk-score for risk stratification in Indian patients undergoing cardiac surgery. Ann Card Anaesth 2013; 16: 163-166. PMID: 23816669 166. Sullivan PG, Wallach JD, Ioannidis JP. Meta-analysis comparing established risk prediction models (EuroSCORE II, STS Score, and ACEF Score) for perioperative mortality during cardiac surgery. Am J Cardiol 2016; 118: 1574-1582. PMID: 27687052 167. Kurazumi H, Mikamo A, Fukamitsu G, et al. Validation of the JapanSCORE versus the logistic EuroSCORE for predicting operative mortality of cardiovascular surgery in Yamaguchi University Hospital. Gen Thorac Cardiovasc Surg 2011; 59: 599-604. PMID: 22231786 168. 梅原伸,齊藤聡,津久井宏,他.JapanSCORE の有用性の検討̶ Logistic EuroSCORE との比較を含めて.日心臓血管外会誌 2013; 42: 94-102. 169. Nabel EG, Braunwald E. A tale of coronary artery disease and myocardial infarction. N Engl J Med 2012; 366: 54-63. PMID: 22216842 170. Patel MR, Calhoon JH, Dehmer GJ, et al. ACC/AATS/AHA/ASE/ ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons. J Am Coll Cardiol 2017; 69: 2212-2241. PMID: 28291663 171. Ohya M, Kadota K, Toyofuku M, et al. AOI LMCA Stenting Registry Investigators. Long-term outcomes after stent implantation for left main coronary artery (from the multicenter assessing optimal percutaneous coronary intervention for left main coronary artery stenting registry). Am J Cardiol 2017; 119: 355-364. PMID: 27887688 172. Farkouh ME, Domanski M, Sleeper LA, et al. FREEDOM Trial Investigators. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 2012; 367: 2375-2384. PMID: 23121323 173. Head SJ, Milojevic M, Daemen J, et al. Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data. Lancet 2018; 391: 939-948. PMID: 29478841 174. Kohsaka S, Goto M, Nagai T, et al. Impact of diabetes among revascularized patients in Japan and the U.S. Diabetes Care 2012; 35: 654- 659. PMID: 22301120 175. Inohara T, Kohsaka S, Goto M, et al. Hypothesis of long-term outcome after coronary revascularization in Japanese patients compared to multiethnic groups in the US. PLoS One 2015; 10: e0128252. PMID: 26023784 176. Kapoor JR, Gienger AL, Ardehali R, et al. Isolated disease of the proximal left anterior descending artery comparing the effectiveness of percutaneous coronary interventions and coronary artery bypass surgery. JACC Cardiovasc Interv 2008; 1: 483-491. PMID: 19463349 177. Aziz O, Rao C, Panesar SS, et al. Meta-analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery. BMJ 2007; 334: 617. PMID: 17337458 178. Byrne RA, Serruys PW, Baumbach A, et al. Report of a European Society of Cardiology-European Association of Percutaneous Cardiovascular Interventions task force on the evaluation of coronary stents in Europe: executive summary. Eur Heart J 2015; 36: 2608-2620. PMID: 26071600 179. Kishi K, Kimura T, Morimoto T, et al. j-Cypher Registry Investigators. Sirolimus-eluting stent implantation for ostial left anterior descending coronary artery lesions: three-year outcome from the j-Cypher Registry. Circ Cardiovasc Interv 2011; 4: 362-370. PMID: 21712527 180. Hannan EL, Zhong Y, Walford G, et al. Coronary artery bypass graft surgery versus drug-eluting stents for patients with isolated proximal left anterior descending disease. J Am Coll Cardiol 2014; 64: 2717- 2726. PMID: 25541122 181. Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/ PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2012; 60: e44-e164. PMID: 23182125 182. Gada H, Kirtane AJ, Kereiakes DJ, et al. Meta-analysis of trials on mortality after percutaneous coronary intervention compared with medical therapy in patients with stable coronary heart disease and objective evidence of myocardial ischemia. Am J Cardiol 2015; 115: 1194-1199. PMID: 25759103 183. Chaitman BR, Hardison RM, Adler D, et al. Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study Group. The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction. Circulation 2009; 120: 2529-2540. PMID: 19920001 184. Yamaji K, Shiomi H, Morimoto T, et al. Effects of age and sex on clinical outcomes after percutaneous coronary intervention relative to coronary artery bypass grafting in patients with triple-vessel coronary artery disease. Circulation 2016; 133: 1878-1891. PMID: 27009629 185. Buszman PE, Buszman PP, Kiesz RS, et al. Early and long-term results of unprotected left main coronary artery stenting: the LE MANS (Left Main Coronary Artery Stenting) registry. J Am Coll Cardiol 2009; 54: 1500-1511. PMID: 19699048 186. Bangalore S, Guo Y, Samadashvili Z, et al. Everolimus-eluting stents or bypass surgery for multivessel coronary disease. N Engl J Med 2015; 372: 1213-1222. PMID: 25775087 187. Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. N Engl J Med 1984; 311: 1333-1339. PMID: 6333636 188. CASS principal investigators and their associates. Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data. Circulation 1983; 68: 939-950. PMID: 6137292 189. European Coronary Surgery Study Group. Long-term results of prospective randomised study of coronary artery bypass surgery in stable angina pectoris. Lancet 1982; 2: 1173-1180. PMID: 6128492 190. Park SJ, Kim YH, Park DW, et al. Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med 2011; 364: 1718-1727. PMID: 21463149 191. Taggart DP, Kaul S, Boden WE, et al. Revascularization for unprotected left main stem coronary artery stenosis stenting or surgery. J Am Coll Cardiol 2008; 51: 885-892. PMID: 18308155 192. Morice MC, Serruys PW, Kappetein AP, et al. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial. Circulation 2014; 129: 2388-2394. PMID: 24700706 193. Stone GW, Sabik JF, Serruys PW, et al. EXCEL Trial Investigators. Everolimus-eluting stents or bypass surgery for left main coronary artery disease. N Engl J Med 2016; 375: 2223-2235. PMID: 27797291 194. Mäkikallio T, Holm NR, Lindsay M, et al. NOBLE study investigators. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial. Lancet 2016; 388: 2743-2752. PMID: 27810312 195. Testa L, Latib A, Bollati M, et al. Unprotected left main revascularization: Percutaneous coronary intervention versus coronary artery bypass. An updated systematic review and meta-analysis of randomised controlled trials. PLoS One 2017; 12: e0179060. PMID: 28658308 196. De Rosa S, Polimeni A, Sabatino J, et al. Long-term outcomes of coronary artery bypass grafting versus stent-PCI for unprotected left main disease: a meta-analysis. BMC Cardiovasc Disord 2017; 17: 240. PMID: 28877676 197. Khan MR, Kayani WT, Ahmad W, et al. Meta-Analysis of Comparison of 5-Year Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Unprotected Left Main Coronary Artery in the Era of Drug-eluting Stents. Am J Cardiol 2017; 120: 1514-1520. PMID: 28886851 198. Palmerini T, Serruys P, Kappetein AP, et al. Clinical outcomes with